Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Liberman, Steven Kriegsman, and Robert Brown

Premium

CytRx announced this week that it has appointed Gregory Liberman as the company’s general counsel and corporate secretary.

In these roles, CytRx said that Liberman is responsible for managing the company’s worldwide legal affairs, policy, and strategy. He will report to CytRx CEO Steven Kriegsman and will serve as secretary to the company’s board of directors.

Liberman has previously worked as a strategic consultant to both private and public companies, said CytRx. He has also served as vice president of legal and corporate affairs, as well as associate general counsel, at Exodus Communications. Prior to this, he was vice president of corporate development and associate general counsel at GlobalCenter.

Lieberman holds a JD from the University of Chicago Law School.

CytRx also announced this week that Robert Brown, founder and director of the Cecil B. Day Laboratory of Neuromuscular Research at Massachusetts General Hospital, has joined the company’s scientific advisory board.

Brown is a professor of neurology at Harvard Medical School and is a recognized expert in the field of neuromuscular diseases such as amyotrophic lateral sclerosis, said CytRx.

Brown is also a member of the Institute of Medicine, the Academy of Neurology, and the American Neurological Association, said the company. He graduated from Harvard Medical School and completed his doctoral training at Oxford University.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.